Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical TrialYan Zhao, Jianzhong Zhang, Chao Ji et al.|American Journal of Clinical Dermatology|2021Cited by 59
Opposing Effects of PI3K/Akt and Smad-Dependent Signaling Pathways in NAG-1-Induced Glioblastoma Cell ApoptosisZhiguo Zhang, Huaizhou Qin|PLoS ONE|2014Cited by 32
Effectiveness of Remimazolam on Preventing Adverse Reactions Caused by Carboprost Tromethamine During Cesarean SectionJianjun Fan, Fei Wang, Zhiguo Zhang et al.|Clinical Therapeutics|2024Cited by 5